# Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease

> **NCT01279577** · PHASE2 · COMPLETED · sponsor: **Dr. Falk Pharma GmbH** · enrollment: 254 (actual)

## Conditions studied

- Crohn´s Disease

## Interventions

- **DRUG:** Low dose TSO
- **DRUG:** Medium dose TSO
- **DRUG:** High dose TSO
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01279577
- **Lead sponsor:** Dr. Falk Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279577, "Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01279577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*